In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify marijuana to be a Plan III drug. This rescheduling will acknowledge that cannabis has legitimate health care uses and should help open up the doorway to investigate on other potential therapy makes us